Daniel Mark James bought ATOS
October 14, 2025 · Form 4 insider transaction
Daniel Mark James bought 578,000 shares of Atossa Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 7 days after the transaction.
Direction
Acquired (buy-side)
Shares
578,000
Price
$0.00
Total value
N/A
InsiderDaniel Mark James
RoleOfficer
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateOctober 14, 2025
Filing dateOctober 21, 2025
Shares owned after578,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options shall vest with respect to 25% on October 14, 2026, with the remaining 75% to vest in equal quarterly installments over the follwing three years, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.